Proton therapy and the European Particle Therapy Network: The past, present and future

D C Weber, J A Langendijk, C Grau, J Thariat

Research output: Contribution to journalArticleAcademicpeer-review

4 Downloads (Pure)

Abstract

Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a dose escalation paradigm and/or a reduced dose-bath to the organs at risk is pursued. It is a costly treatment with an additional cost factor of 2–3 when compared to photon radiotherapy. Notwithstanding the 180′000 patients treated with protons, scars robust clinical evidence is available to justify the administration of this treatment modality. The European Particle Therapy Network (EPTN) was created in 2015 to answer the critical European needs for cooperation among protons and carbon ions centres in the framework of clinical research networks. EPTN with other European groups will launch a number of prospective clinical trials that could be practice changing if positive. Alternative way to generate clinical data could be provided by alternative methodologies, such as the Dutch model-based approach, or could be provided by European infrastructure projects.

Original languageFrench
Pages (from-to)687-690
Number of pages4
JournalCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Volume24
Issue number6-7
Early online date1-Aug-2020
DOIs
Publication statusPublished - Oct-2020
EventMeeting of the Societe-Francaise-de-Radiotherapie-Oncologique (SFRO) - Paris, France
Duration: 8-Oct-2020 → …

Keywords

  • Proton therapy
  • EPTN
  • European research networks
  • Cancer
  • European research infrastructure
  • COST-EFFECTIVENESS
  • CLINICAL-TRIALS
  • RADIATION
  • REDUCTION

Cite this